NEWS
Atelerix and Rodon Global partner to integrate ...
By integrating Atelerix’s unique cryo-free preservation products within Rodon’s dynamic logistics offering, the collaboration will significantly broaden access to safe shipping and storage solutions for temperature-sensitive biomaterials, without freezing. Samples...
Atelerix and Rodon Global partner to integrate ...
By integrating Atelerix’s unique cryo-free preservation products within Rodon’s dynamic logistics offering, the collaboration will significantly broaden access to safe shipping and storage solutions for temperature-sensitive biomaterials, without freezing. Samples...
Overcoming Organoid Preservation Challenges in ...
Contract Research Organisations are turning to organoids to deliver more predictive models for drug discovery and toxicology studies. Atelerix’s WellReady™ technology allows these fragile 3D systems to be preserved at...
Overcoming Organoid Preservation Challenges in ...
Contract Research Organisations are turning to organoids to deliver more predictive models for drug discovery and toxicology studies. Atelerix’s WellReady™ technology allows these fragile 3D systems to be preserved at...
From Lab to Market: Recent Advances and Commerc...
Organoids are transforming biomedical research, offering human-relevant models that surpass traditional 2D cell cultures and animal testing. With rapid advances in bioprinting, organ-on-a-chip integration, and regulatory endorsement, organoids are moving...
From Lab to Market: Recent Advances and Commerc...
Organoids are transforming biomedical research, offering human-relevant models that surpass traditional 2D cell cultures and animal testing. With rapid advances in bioprinting, organ-on-a-chip integration, and regulatory endorsement, organoids are moving...
Sunil Shah and Dr Catherine Elton join Atelerix...
Atelerix is delighted to welcome Sunil Shah as Chair and Dr Catherine Elton as Non-Executive Director to help drive the company’s global expansion of its pioneering non-cryogenic cell preservation technology.
Sunil Shah and Dr Catherine Elton join Atelerix...
Atelerix is delighted to welcome Sunil Shah as Chair and Dr Catherine Elton as Non-Executive Director to help drive the company’s global expansion of its pioneering non-cryogenic cell preservation technology.
Mini Organs, Major Impact: How Organoids Are Re...
Organoids, miniature, self-organising 3D tissue cultures, are transforming drug development and personalised medicine by offering more physiologically relevant, patient-specific models than traditional 2D cultures and animal testing. This article explores...
Mini Organs, Major Impact: How Organoids Are Re...
Organoids, miniature, self-organising 3D tissue cultures, are transforming drug development and personalised medicine by offering more physiologically relevant, patient-specific models than traditional 2D cultures and animal testing. This article explores...
Grant Writing That Stands Out: How Ambient Cell...
Securing research funding is a competitive process. Review panels look for more than just sound science - they’re also seeking evidence of novel thinking, technical feasibility, and efficient resource use....
Grant Writing That Stands Out: How Ambient Cell...
Securing research funding is a competitive process. Review panels look for more than just sound science - they’re also seeking evidence of novel thinking, technical feasibility, and efficient resource use....
